Linda de Munck

11PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 27, 2025
Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.

Marie-France Jilderda, Yi Zhang, Valerie Rebattu

|Jul 09, 2024
Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade.

Rebecca L O'Leary, Lucien E M Duijm, Liesbeth J Boersma

|Apr 18, 2024
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.

M C Liefaard, A van der Voort, M van Seijen

|Apr 10, 2024
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).

Sabine R de Wild, Lori M van Roozendaal, Johannes H W de Wilt

|Nov 07, 2023
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time.

Linda de Munck, Anouk H Eijkelboom, Johannes D M Otten

|Aug 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.

Maartje van Seijen, Esther H Lips, Liping Fu

Pageof 2

Frequent Collaborators

2 joint publications

Gerrit-Jan Liefers

2 joint publications

Jelle Wesseling

2 joint publications

Esther Bastiaannet

2 joint publications

Kelly M de Ligt